5.26
+4.37%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About SBC Medical Group Holdings
From its filings with the US Securities and Exchange Commission
SBC Medical Group Holdings is based in Irvine, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker SBC. The SEC classifies its business as offices & clinics of doctors of medicine. In the fiscal year to 31 December 2025, it reported revenue of $173.6m and net income of $51.0m. At that date it held total assets of $380.4m and shareholders' equity of $248.3m.
We were originally incorporated in Delaware on March 11, 2022 under the name “Pono Capital Two, Inc.,” referred to herein as “Pono,” as a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
On August 9, 2022, Pono consummated its IPO of 11,500,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares” and with respect to the warrants included in the Units, the “Public Warrants”) (the “Pono IPO”).
Simultaneously with the consummation of the closing of the Pono IPO, Pono consummated the private placement of an aggregate of 634,375 units (the “Placement Units”) at a price of $10.00 per Placement Unit in a private placement to the Sponsor (the “Private Placement”).
On September 26, 2022, the Class A common stock and Public Warrant included in the Units began separate trading on The Nasdaq Global Market under the symbols “PTWO” and “PTWOW,” respectively.
Quoted from its 10-K, filed 27 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- N/A
- Industry
- N/A
- Listed since
- 26 Sept 2022
- Employees
- 863
- Head office
- 200 SPECTRUM CENTER DR., IRVINE, CA, 92618
- Incorporated in
- DE
- Classification
- Services-Offices & Clinics of Doctors of Medicine
- Filer status
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Leadership
Pay as last reported
- Dr. Yoshiyuki AikawaChairman of the Board, Chief Executive Officer, since 2024$14.5m
- Mr. Yuya YoshidaChief Financial Officer, Chief Operating Officer, Director, since 2024$304,404
- Mr. Shinya InoueChief Marketing Officer
- Ms. Miki YamazakiChief Strategy Officer
- Mr. Akira KomatsuSecretary
- Mr. Ken EdahiroIndependent Director$41,724
- Mr. Fumitoshi FujiwaraIndependent Director$83,448
- Dr. Mike SayamaIndependent Director$41,724
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Pono Capital Two, Inc. has a strong IPO listing date of 26 September 2022 for business combinations.
- The company operates with 863 employees in Honolulu, Hawaii, supporting its growth strategy.
- Pono Capital Two, Inc. is an early stage emerging growth company with no prior operations.
Weaknesses
- Pono Capital Two, Inc. has generated no revenues since its formation.
- The company has not engaged in any operations or business activities to date.
- Pono Capital Two, Inc. is subject to all risks of early stage emerging growth companies.
Opportunities
- Pono Capital Two, Inc. can pursue business combinations across various industries and geographies.
- The firm has the potential to acquire assets in the Health Care sector for growth.
- Pono Capital Two, Inc. can target the Financials sector for strategic acquisitions.
Threats
- Pono Capital Two, Inc. faces risks associated with early stage emerging growth companies.
- The company has no operational history to mitigate business combination risks.
- Pono Capital Two, Inc. may struggle to find suitable business combinations in a competitive market.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.